To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
PCI Pharma, backed by Partners Group, Frazier Healthcare, kicks off sale process
A deal is expected to value the provider of contract manufacturing services and packaging for pharmaceutical companies in the $2.5bn to $3bn range.
